Wells Pharma of Houston LLC: Drug Recall
Recall #D-0141-2024 · 11/22/2023
Class II: Risk
Recall Details
- Recall Number
- D-0141-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Wells Pharma of Houston LLC
- Status
- Completed
- Date Initiated
- 11/22/2023
- Location
- Houston, TX, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 825 syringes
Reason for Recall
Lack of assurance of sterility.
Product Description
ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10
Distribution Pattern
Philadelphia, Pennsylvania.
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.